Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Interim guidance on the use of Imvamune® in the context of a routine immunization program

2022 ∙ Castrejon, M. M. Leal, I. de Jesus Pereira Pinto, T. Guzmán-Holst, A.

The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis

2022 ∙ ACIP

Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 ∙ CAVEI

CAVEI recommendation on vaccination against monkeypox in Chile

2022 ∙ NACI

NACI Rapid Response: Updated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks

2022 ∙ CoNaIn

Vaccine for prevention of monkeypox

2022 ∙ CoNaIn

CoNaIn 3rd August 2022 meeting minutes

2022 ∙ NACI, Public Health Agency of Canada

NACI Rapid Response - Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada

2022 ∙ ACIP

Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices

2019 ∙ Dolhain, J. Janssens, W. Sohn, W. Y. Dindore, V. Mukherjee, P.

Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region